MVC Stock Analysis: Metrovacesa | MC
Real Estate - Development | MC, Spain | Market Cap: 1.819m EUR | 12M Return: 23.1% | ES0105122024 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 2.32M
Rev. Trend: 74.4%
Qual. Beats: 0
Warnings
Tailwinds
No distinct edge detected
Seasonality
Metrovacesa S.A. is a Madrid-based real estate developer specializing in the residential and commercial sectors across Spain. Founded in 1918, the company manages the full development lifecycle, including land acquisition, project planning, and the final sale of properties. Its business model focuses on liquidating a large land bank to capitalize on housing demand in major Spanish urban centers.
The Spanish real estate development sector is characterized by high capital intensity and sensitivity to interest rate fluctuations, which directly impact mortgage affordability and construction financing costs. Unlike Real Estate Investment Trusts (REITs) that focus on recurring rental income, developers like Metrovacesa generate revenue primarily through one-time asset divestments and unit deliveries.
Investors can evaluate the companys land bank valuation and project pipeline in greater detail on ValueRay. This historical developer remains a significant player in the Iberian property market, maintaining a strategic focus on sustainable urban growth.
- Spanish residential demand and mortgage interest rate fluctuations drive sales volume
- Strategic land bank monetization accelerates cash flow and dividend distribution capacity
- Rising construction material costs and labor shortages compress development profit margins
- Regulatory changes in Spanish housing laws impact rental yields and project viability
- Institutional demand for commercial turnkey projects influences long-term revenue stability
| Net Income: 56.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.10 > 0.02 and ΔFCF/TA 5.68 > 1.0 |
| NWC/Revenue: 23.98% < 20% (prev 232.6%; Δ -208.6% < -1%) |
| CFO/TA 0.10 > 3% & CFO 217.1m > Net Income 56.9m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 2.48 > 1.5 & < 3 |
| Outstanding Shares: last quarter (151.6m) vs 12m ago 0.02% < -2% |
| Gross Margin: 23.13% > 18% (prev 28.11%; Δ -4.98% > 0.5%) |
| Asset Turnover: 30.33% > 50% (prev 27.06%; Δ 3.27% > 0%) |
| Interest Coverage Ratio: -0.78 > 6 (EBIT TTM -17.0m / Interest Expense TTM 21.9m) |
| A: 0.08 (Total Current Assets 284.8m - Total Current Liabilities 115.0m) / Total Assets 2.26b |
| B: -0.09 (Retained Earnings -205.0m / Total Assets 2.26b) |
| C: -0.01 (EBIT TTM -17.0m / Avg Total Assets 2.34b) |
| D: 1.68 (Book Value of Equity 1.41b / Total Liabilities 843.8m) |
| Altman-Z'' = 1.91 = BBB |
| DSRI: 1.21 (Receivables 96.4m/73.2m, Revenue 708.4m/653.1m) |
| GMI: 1.22 (GM 28.11% / 23.13%) |
| AQI: 5.47 (AQ_t 0.87 / AQ_t-1 0.16) |
| SGI: 1.08 (Revenue 708.4m / 653.1m) |
| TATA: -0.07 (NI 56.9m - CFO 217.1m) / TA 2.26b) |
| Beneish M = 0.05 (Cap -4..+1) = D |
As of November 22, 2026, the stock is trading at EUR 11.32 with a total of 203,813 shares traded. Over the past week, the price has changed by -5.67%, over one month by +8.43%, over three months by +6.79% and over the past year by +23.11%.
Current recommended Stop Loss: 11.00 (which is 2.8% or 1.3 ATR below the current price).
Metrovacesa has no consensus analysts rating.
P/E Trailing = 30.7692
P/E Forward = 79.3651
P/S = 2.0373
P/B = 1.4037
Revenue TTM = 708.4m EUR
EBIT TTM = -17.0m EUR
EBITDA TTM = -15.8m EUR
Long Term Debt = 253.7m EUR (from longTermDebt, last quarter)
Short Term Debt = 115.0m EUR (from shortTermDebt, last quarter)
Debt = 368.7m EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 167.1m EUR (calculated: Debt 368.7m - CCE 201.5m)
Enterprise Value = 1.99b EUR (1.82b + Debt 368.7m - CCE 201.5m)
Interest Coverage Ratio = -0.78 (Ebit TTM -17.0m / Interest Expense TTM 21.9m)
EV/FCF = 9.15x (Enterprise Value 1.99b / FCF TTM 217.1m)
FCF Yield = 10.93% (FCF TTM 217.1m / Enterprise Value 1.99b)
FCF Margin = 30.65% (FCF TTM 217.1m / Revenue TTM 708.4m)
Net Margin = 8.03% (Net Income TTM 56.9m / Revenue TTM 708.4m)
Gross Margin = 23.13% ((Revenue TTM 708.4m - Cost of Revenue TTM 544.5m) / Revenue TTM)
Gross Margin QoQ = none% (prev none%)
Tobins Q-Ratio = 0.88 (Enterprise Value 1.99b / Total Assets 2.26b)
Interest Expense / Debt = 5.93% (Interest Expense 21.9m / Debt 368.7m)
Taxrate = 25.70% (18.6m / 72.5m)
NOPAT = -12.6m (EBIT -17.0m * (1 - 25.70%)) [loss with tax shield]
Current Ratio = 2.48 (Total Current Assets 284.8m / Total Current Liabilities 115.0m)
Debt / Equity = 0.26 (Debt 368.7m / totalStockholderEquity, last quarter 1.41b)
Debt / EBITDA = -10.61 (negative EBITDA) (Net Debt 167.1m / EBITDA -15.8m)
Debt / FCF = 0.77 (Net Debt 167.1m / FCF TTM 217.1m)
Total Stockholder Equity = 1.46b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.43% (Net Income 56.9m / Total Assets 2.26b)
RoE = 3.89% (Net Income TTM 56.9m / Total Stockholder Equity 1.46b)
RoCE = -0.99% (EBIT -17.0m / Capital Employed (Equity 1.46b + L.T.Debt 253.7m))
RoIC = -0.57% (negative operating profit) (NOPAT -12.6m / Invested Capital 2.22b)
WACC = 6.71% (E(1.82b)/V(2.19b) * Re(7.18%) + D(368.7m)/V(2.19b) * Rd(5.93%) * (1-Tc(0.26)))
Discount Rate = 7.18% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 91.97 | Cagr: 0.02%
[DCF] Terminal Value 77.97% ; FCFF base≈168.3m ; Y1≈192.9m ; Y5≈283.9m
[DCF] Fair Price = 27.07 (EV 4.27b - Net Debt 167.1m = Equity 4.10b / Shares 151.6m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: N/A | # QB: 0
Revenue Correlation: 74.39 | Revenue CAGR: 12.82% | SUE: 0.29 | # QB: 0
EPS current Year (2026-12-31): EPS=0.43 | Chg30d=+0.00% | Revisions=-25% | GrowthEPS=-24.1% | GrowthRev=+5.2%
EPS next Year (2027-12-31): EPS=0.45 | Chg30d=+0.00% | Revisions=-25% | GrowthEPS=+3.5% | GrowthRev=+4.8%
[Analyst] Revisions Ratio: -40% (up=0, down=2)